iHuman Co-CEO Li Teng files initial Form 3

iHuman Inc. filed an initial Form 3 for Li Teng, who serves as Co-Chief Executive Officer.

Accepted by SEC EDGAR 07/09/2026 - 07:28 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

iHuman Inc. filed an initial Form 3 for Li Teng, who serves as Co-Chief Executive Officer. This filing establishes Li Teng’s status as a reporting insider of the company. The data provided show no reported purchases, sales, or other equity transactions in this filing.

Key Terms

Co-Chief Executive Officer

1 terms

Co-Chief Executive Officer financial

"officer_title": "Co-Chief Executive Officer""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the iHuman Inc. (IH) Form 3 filing for Li Teng show?

The Form 3 filing shows that Li Teng is a Co-Chief Executive Officer and now a reporting insider of iHuman Inc. It is an initial ownership statement and, in this case, reports no equity transactions or positions in the summarized data.

Did Li Teng buy or sell any iHuman Inc. (IH) shares in this Form 3?

No transactions are reported for Li Teng in this Form 3. The transaction summary shows zero buys, zero sells, and no other types of share movements, indicating the filing is purely an initial insider status disclosure.

What is Li Teng’s role at iHuman Inc. (IH) as disclosed in the Form 3?

Li Teng is identified as a Co-Chief Executive Officer of iHuman Inc. This senior executive role makes Li Teng subject to insider reporting rules, requiring filings like Form 3, 4, and 5 to disclose equity ownership and future changes.

Why is a Form 3 filing for iHuman Inc. (IH) important to investors?

A Form 3 marks the point when an executive or large holder becomes a reportable insider. For iHuman Inc., Li Teng’s Form 3 means future changes in their holdings must be reported, improving transparency around insider equity activity for investors.

Does the iHuman Inc. (IH) Form 3 for Li Teng list any derivative securities?

The derivative summary section for this Form 3 is empty, indicating no options, warrants, or other derivative securities are reported for Li Teng in this filing. It focuses solely on establishing insider status rather than detailing specific holdings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Li Teng

(Last) (First) (Middle)

TOWER 306, NO.86 BEIYUAN ROAD,

CHAOYANG DISTRICT

(Street)

BEIJING BEIJING 100101

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/29/2026

3. Issuer Name and Ticker or Trading Symbol
iHuman Inc. [ IH ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Co-Chief Executive Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Teng Li	07/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)